Clinical trial
Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study
NCT00426946 · Geha Mental Health Center, Other · Unknown status
Key facts
| NCT number | NCT00426946 |
|---|---|
| Title | Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study |
| Official title | Phase 3 Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study |
| Lead sponsor | Geha Mental Health Center, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Reboxetine |
| Enrollment | 60 |
| Start date | Jan 1, 2005 |
| First posted | Jan 25, 2007 |
| Last update posted | Jan 25, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: